Recent Blog Posts

View Post: ACHIEVE OPTIMAL LEVEL OF HEALTH & MAXIMUM LEVEL OF INDEPENDENCE ...
10 hours ago by PHYSICAL MEDICINE & REHABILITATION HOSPITAL  
Some medications can enhance the action of Coumadin and cause excessive blood thinning and life-threatening bleeding. A few examples of such medications include Aspirin, acetaminophen (Tylenol and others), alcohol, ibuprofen (Motrin), .... Low-dose aspirin, as prescribed by your doctor for specific medical reasons such as heart attack or stroke prevention or to prevent clotting of artificial heart valves (usually these dosages are 81-325 mg per day), should be continued. ...
View Blog: ACHIEVE OPTIMAL LEVEL OF HEALTH & MAXIMUM... - http://pmr-hospital.blogspot.com/

---

View Post: American Heart Association Late-Breaking Clinical Trial Report ...
15 Nov 2009
American Heart Association Late-Breaking Clinical Trial Report: New Reversible Antiplatelet Drug no More Effective Than Irreversible One in PCI ...Study highlights: ...- A new reversible intravenous blood thinner did not show superiority. ... heart attack or ischemia-related revascularization in the 48 hours after angioplasty, researchers reported in a late-breaking clinical trial presentation at the American Heart Association's Scientific Sessions 2009. ...
View Blog: Latest Biology Technology from Bio-Medicine.Org - http://www.bio-medicine.org/biology-technology-1/

---

View Post: Plavix works in men and women, with differences - World News ...
10 Nov 2009
They analyzed data from five major studies of more than 80000 people, 30 percent of them women, and found that Plavix or clopidogrel cut the risk of having a heart attack or stroke by 16 percent in men and by 7 percent in women. ... Garratt said Plavix will soon go generic, but he said the findings may cause drugmakers to work harder to enroll women in studies of new anti-platelet drugs, such as AstraZeneca's experimental blood-thinning drug Brilinta. ...
View Blog: World News Financial News Breaking US and... - http://www.goozad.com/index.php

---

View Post: J&J, Boston Scientific, Medtronic and Abbott Among Rivals ...
2 Oct 2009 by Ron Winslow  
On the drug side are Bristol-Myers Squibb and Sanofi-Aventis, co-marketers of Plavix, the antiplatelet drug that rode the stent boom during much of the last decade to become the pharmaceutical industry's second biggest selling drug after ... Right now, doctors aren't sure how long patients need to be on the regimens drug to protect them from a heart-attack-causing blood clot. “That creates a lot of variation in medical practice,” Mauri says, adding that it also helps fuel ...
View Blog: WSJ.com: Health Blog - http://blogs.wsj.com/health/

---

View Post: Good News for Bristol-Myers – Analyst Blog
Stock Market News ...
23 Nov 2009 by Zacks Market Commentaries   ...
View Blog: http://www.straightstocks.com/

---

View Post: Aniara
New In Coagulation: October 2009: What's New In Coagulation
4 Oct 2009 by Donna Castellone   ...
View Blog: http://www.aniara.com/learning-center/New-In-Coagulation/Coagulation-News/Coagulation.aspx

---

View Post: Direct-To-Consumer Ads Linked To Higher Medicaid Costs
Visit ...
24 Nov 2009 by Anna Tomova   ...
View Blog: http://visitbulgaria.info/

---

View Post: AstraZeneca Enters the Race for the Next Plavix-Minyanville
19 Nov 2009
Treatment with Brilinta resulted in a reduction of death, heart attack, and stroke for at least one year, without an increase in major bleeding. Brilinta's introduction into the market could chip away at the Plavix domination in the category. ... While Brilinta has a greater efficacy than the blockbuster blood thinner, a risk of bleeding could present a challenge when it tries to take on Plavix. “This direct-acting reversible inhibitor should provide an interesting option ...
View Blog: Minyanville - http://www.minyanville.com/

---

View Post: AHA: cangrelor fails to find a championship season « CardioBrief
15 Nov 2009 by Larry Husten  
15, 2009 — A new reversible blood thinner for angioplasty patients wasn't superior over placebo for its primary combined endpoint of heart attack, all-cause mortality and need for revascularization, but it reduced mortality and in-stent .... evidence of rapid, potent antiplatelet effect,” said Robert A. Harrington, M.D. “This is particularly important in specific patient groups, such as those urgently requiring PCI or surgery, those who cannot receive oral medication, ...
View Blog: CardioBrief - http://cardiobrief.org/

---

View Post: Should kids stay away from soy?
Washington Examiner
25 Oct 2009 by Mehment Oz   ...
View Blog: http://www.washingtonexaminer.com/templates/rss

---